发明名称 Methods for treating parkinson's disease by optically stimulating target cells
摘要 Methods, systems and devices are implemented in connection with light-responsive ion channel molecules. One such method is implemented using a light-activated ion channel molecule that responds to a light stimulus. The method includes engineering the light-activated ion channel molecule in a cell; and activating the ion channel molecule, in response to light stimulus that is provided to the ion channel molecule and that has properties that do not activate a ChR2 ion channel, to allow ions to pass through the light-activated ion channel molecule.
申请公布号 US9394347(B2) 申请公布日期 2016.07.19
申请号 US201514694845 申请日期 2015.04.23
申请人 The Board of Trustees of the Leland Stanford Junior University 发明人 Deisseroth Karl;Zhang Feng;Gradinaru Viviana
分类号 C07K14/405;C07K14/47;C12N15/75;C12N15/85;C12N15/86;C12N7/00;A61N5/06;A61K41/00;A61K48/00;A61K31/713;C12N15/79;A61N5/067 主分类号 C07K14/405
代理机构 Bozicevic, Field & Francis LLP 代理人 Bozicevic, Field & Francis LLP ;Borden Paula A.
主权项 1. A method for treating Parkinson's Disease in an individual, the method comprising: a) implanting into the individual a device comprising: i) a recombinant expression vector comprising a nucleotide sequence encoding a Volvox carteri light-activated ion channel (VChR1) protein to provide localized depolarization of afferent axons of the subthalamic nucleus (STN); andii) a light-delivery mechanism,wherein the VChR1 protein is produced in the afferent axons; and b) activating the VChR1 protein with the light-delivery mechanism, thereby depolarizing the afferent axons and treating the disease.
地址 Stanford CA US